Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2023-09-26

Clinical Trial Update: Dexamethasone Administered Via the Epidural Catheter as an Adjunct in Patients Undergoing Cesarean Delivery [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating dexamethasone via epidural catheter as an adjunct in cesarean delivery has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: Henry Ford Health System | Conditions: Post Operative Pain | Phase 4 | Status: WITHDRAWN